{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T02:43:08Z","timestamp":1776739388237,"version":"3.51.2"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Ethambutol is an antitubercular drug that is commonly used in the areas of the world that is endemic to tuberculosis. It is used in infections caused by <jats:italic>Mycobacterium tuberculosis<\/jats:italic> and some non-tuberculous infections caused by Mycobacterium species. Ethambutol related toxic optic neuropathy remains one of the most concerning adverse effects of the medication in addition to other non-specific side effects like peripheral neuropathy, nausea, vomiting, joint pain and rash. Recently the guidelines for treatment of tuberculosis in some countries where tuberculosis (TB) is endemic have been revised to allow for fixed dose combinations (wherein a single tablet contains a fixed strength of isoniazid, rifampicin, pyrazinamide, and ethambutol) and longer duration of treatment with ethambutol. Thus, it is anticipated that there will be an increase in ethambutol toxic optic neuropathy. In this minireview we plan to discuss the clinical features, neuro-ophthalmic evaluation, screening and diagnosis of ethambutol toxic optic neuropathy. We will also discuss the available treatment options for this condition.<\/jats:p>","DOI":"10.3389\/fneur.2025.1626909","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T04:13:55Z","timestamp":1757564035000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Ethambutol optic neuropathy"],"prefix":"10.3389","volume":"16","author":[{"given":"Padmaja","family":"Sudhakar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kishor","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonse Ashwini","family":"Kini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/archopht.1962.00960020566009","article-title":"Ocular manifestations of ethambutol","volume":"67","author":"Carr","year":"1962","journal-title":"Arch Ophthalmol"},{"key":"ref2","first-page":"278","article-title":"Two cases of neuritis retrobulbaris due to orally administered ethambutol","volume":"14","author":"Harada","year":"1963","journal-title":"Nihon Ganka Kiyo"},{"key":"ref3","first-page":"765","volume-title":"Antitubercular drugs essential of medical pharmacology","author":"Tripathi","year":"2013"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2003300","DOI":"10.1183\/13993003.03300-2020","article-title":"World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 202 update","volume":"57","author":"Mirzayev","year":"2021","journal-title":"Eur Respir J"},{"key":"ref5","first-page":"56","article-title":"Ocular toxicity of ethambutol","volume":"12","author":"Chan","year":"2006","journal-title":"Hong Kong Med J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1517\/14740338.5.5.615","article-title":"Update on ethambutol optic neuropathy","volume":"5","author":"Fraunfelder","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/WNO.0b013e31818e3c6b","article-title":"Incidence and clinical features of ethambutol-induced optic neuropathy in Korea","volume":"28","author":"Lee","year":"2008","journal-title":"J Neuroophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1089\/jop.1997.13.473","article-title":"Reversibility of ethambutol optic neuropathy","volume":"13","author":"Tsai","year":"1997","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"ref10","first-page":"54","article-title":"Ethambutol optic neuropathy: vigilance and screening, the keys to prevent blindness with the revised anti-tuberculous therapy regimen","volume":"69","author":"Saxena","year":"2021","journal-title":"J Assoc Physicians India"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.4103\/ijo.IJO_3746_20","article-title":"Ethambutol toxicity: expert panel consensus for the primary prevention, diagnosis and management of ethambutol-induced optic neuropathy","volume":"69","author":"Saxena","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/ICU.0000000000000416","article-title":"Ethambutol optic neuropathy","volume":"28","author":"Chamberlain","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"ref13","volume-title":"Ethambutol efficacy and toxicity: Literature review and recommendations for daily and intermittent dosage in children","year":"2006"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1136\/bjophthalmol-2012-301870","article-title":"Ethambutol-induced optic neuropathy: a nationwide population-based study from Taiwan","volume":"96","author":"Chen","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/WNO.0b013e31818f138f","article-title":"Ethambutol optic neuropathy: how we can prevent 100,000 new cases of blindness each year","volume":"28","author":"Sadun","year":"2008","journal-title":"J Neuroophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/2320-8775.196644","article-title":"Recent changes in technical and operational guidelines for tuberculosis control programme in India-2016: a paradigm shift in tuberculosis control","volume":"5","author":"Chaudhuri","year":"2017","journal-title":"J Assoc Chest Physicians"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.5588\/ijtld.15.0275","article-title":"Incidence of toxic optic neuropathy with low dose ethambutol","volume":"20","author":"Yang","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0732-8893(97)00217-4","article-title":"The role of copper on ethambutol\u2019s antimicrobial action and implications for ethambutol-induced optic neuropathy","volume":"30","author":"Kozak","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1242\/dmm.019737","article-title":"Ethambutol induces impaired autophagic flux and apoptosis in the rat retina","volume":"8","author":"Huang","year":"2015","journal-title":"Dis Model Mech"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.taap.2008.11.006","article-title":"Ethambutol-induced toxicity is mediated by zinc and lysosomal membrane permeabilization in cultured retinal cells","volume":"235","author":"Chung","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s11095-022-03227-9","article-title":"Exploration of the plausible mechanism of ethambutol induced ocular toxicity by using proteomics informed physiologically based pharmacokinetic (PBPK) modeling","volume":"39","author":"Balhara","year":"2022","journal-title":"Pharm Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.5588\/ijtld.11.0766","article-title":"Incidence of ethambutol-related visual impairment during treatment of active tuberculosis","volume":"17","author":"Ezer","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000309592","article-title":"Blue-yellow colour vision changes as early symptoms of ethambutol oculotoxicity","volume":"191","author":"Polak","year":"1985","journal-title":"Ophthalmologica"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/WNO.0000000000000095","article-title":"Optic chiasm involvement on MRI with ethambutol-induced bitemporal hemianopia","volume":"34","author":"Osaguona","year":"2014","journal-title":"J Neuroophthalmol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/WNO.0b013e318205a148","article-title":"Bitemporal visual field defects in ethambutol-induced optic neuropathy","volume":"31","author":"Kho","year":"2011","journal-title":"J Neuroophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1016\/j.jfo.2012.12.008","article-title":"H\u00e9mianopsie bitemporale r\u00e9v\u00e9latrice d\u2019une atteinte toxique s\u00e9v\u00e8re \u00e0 l\u2019\u00e9thambutol [Bitemporal hemianopia as presenting sign of severe ethambutol toxicity]","volume":"36","author":"Boulanger","year":"2013","journal-title":"J Francois Ophtalmologie"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1136\/bjo.2006.113118","article-title":"Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy","volume":"91","author":"Chai","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00417-004-1053-1","article-title":"Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy","volume":"243","author":"Zoumalan","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.14744\/bej.2020.96658","article-title":"Evaluation of the long-term effect of ethambutol usage on the retinal nerve Fiber layer using spectral-domain optical coherence tomography","volume":"5","author":"Varan","year":"2020","journal-title":"Beyoglu Eye J"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"114176","DOI":"10.1016\/j.fct.2023.114176","article-title":"Potential underlying mechanisms of ethambutol induced optic neuropathy: evidence from in vitro to clinical studies","volume":"182","author":"Kulniwatcharoen","year":"2023","journal-title":"Food Chem Toxicol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1089\/jop.2009.0064","article-title":"Serial retinal nerve fiber layer changes in patients with toxic optic neuropathy associated with antituberculosis pharmacotherapy","volume":"25","author":"Kim","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3109\/15569527.2015.1079784","article-title":"Visual function test for early detection of ethambutol induced ocular toxicity at the subclinical level","volume":"35","author":"Kim","year":"2016","journal-title":"Cutan Ocul Toxicol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1136\/bjo.2008.148502","article-title":"Prospective evaluation of visual function for early detection of ethambutol toxicity","volume":"93","author":"Menon","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1007\/s00417-015-3150-8","article-title":"Longitudinal analysis of retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in ethambutol-induced optic neuropathy","volume":"253","author":"Han","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4103\/1673-5374.179061","article-title":"Macular thickness as a predictor of loss of visual sensitivity in ethambutol-induced optic neuropathy","volume":"11","author":"Peng","year":"2016","journal-title":"Neural Regen Res"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3109\/15569527.2014.954715","article-title":"Follow up of retinal nerve fiber layer thickness with optic coherence tomography in patients receiving antitubercular treatment may reveal early optic neuropathy","volume":"34","author":"Gumus\u00b8","year":"2015","journal-title":"Cutan Ocul Toxicol"},{"key":"ref37","first-page":"847","article-title":"Visual evoked responses in ethambutol induced optic neuritis","volume":"45","author":"Srivastava","year":"1997","journal-title":"J Assoc Physicians India"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4103\/tjo.tjo_27_21","article-title":"Ethambutol optic neuropathy with correspondent chiasmitis manifestation in magnetic resonance imaging","volume":"12","author":"Lin","year":"2021","journal-title":"Taiwan J Ophthalmol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ijtb.2020.09.014","article-title":"Neuroimaging in ethambutol induced optic neuropathy: MRI in time can save the vision","volume":"68","author":"Murumkar","year":"2021","journal-title":"Indian J Tuberc"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.prrv.2010.09.005","article-title":"Treatment of paediatric TB: revised WHO guidelines","volume":"12","author":"Graham","year":"2011","journal-title":"Paediatr Respir Rev"},{"key":"ref41","first-page":"1318","article-title":"Ethambutol dosage for the treatment of children: literature review and recommendations","volume":"10","author":"Donald","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.kjms.2015.05.004","article-title":"Incidence and prognostic factor of ethambutol-related optic neuropathy: 10-year experience in southern Taiwan","volume":"31","author":"Chen","year":"2015","journal-title":"Kaohsiung J Med Sci"},{"key":"ref43","first-page":"15","article-title":"Ocular ethambutol toxicity: is it reversible?","volume":"13","author":"Kumar","year":"1993","journal-title":"J Clin Neuroophthalmol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"754676","DOI":"10.3389\/fcell.2021.754676","article-title":"Mitochondrial Mutations in Ethambutol-Induced Optic Neuropathy","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Cell Dev Biol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/WNO.0000000000000445","article-title":"Re-treatment with ethambutol after toxic optic neuropathy","volume":"37","author":"Bouffard","year":"2017","journal-title":"J Neuroophthalmol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1626909\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T04:13:58Z","timestamp":1757564038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1626909\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":45,"alternative-id":["10.3389\/fneur.2025.1626909"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1626909","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"article-number":"1626909"}}